On 21 October 2026, XINMING CHINA (02699.HK) said its chairman and an independent director quit, Zhang Yu joined the board, leaving independents below three.
On 22 October 2026, UISEE TECH (01511.HK) supplied driver assistance software for the new Buick LaCrosse and Cadillac XT5, reusing one platform across models.
On 22 October 2026, BLOKS (00325.HK) said Smart Bloks sold 3,849,000 shares at HK$ 65.28 each, cutting its stake from 3.57% to 2.01% and Zhu Weisong's to 52.03%.
On 21 October 2026, SHIMAO GROUP (00813.HK) said receivers will sell the hotel and business to Oceanfront Hong Kong for HK$ 2.7 billion, closing by end-2026.
On 21 Oct 2026, SUNFONDA GP (01771.HK) gave valuation details, valuing the Wuxi property at RMB35m and the target at RMB20.15m; the circular is due by 25 Nov.
On 21 Oct 2026, SIHUAN PHARM (00460.HK) said subsidiary Xuanzhu Bio presented Phase III data showing anlarazole sodium met its endpoint in reflux oesophagitis.
On 21 Oct 2026, XUANZHUBIO-B (02575.HK) said Phase III data showed anlarazole sodium met its endpoint in reflux oesophagitis, with 88.4% healing in FAS.
On 21 Oct 2026, HPLIVING TECH (01682.HK) said its unit granted a HK$30m revolving loan facility priced at 1M HIBOR plus 0.5%.
On 21 Oct 2026, KINTOR PHARMA-B (09939.HK) said its KT-939 inhibitor won a Chinese invention patent grant notice; an NMPA cosmetic filing was filed on 18 Sept.
On 21 Oct 2026, CH MODERN D (01117.HK) exercised a redemption right to buy Zhongken Fund's 25.4% Wuhe stake for RMB 667,488,628.41, ahead of schedule.
On 21 Oct 2026, WINFULL GP (00183.HK) said its circular on a subsidiary disposal, due by 21 October, is delayed and it seeks a Rule 14.41(a) waiver.
On 21 Oct 2026, WELLCELL HOLD (02477.HK) said substantial shareholder Hang Fung sold 716mn shares, about 14.93% of the company, for roughly HK$107mn.
On 21 Oct 2026, FRIENDTIMES (06820.HK) said two units redeemed China Merchants Bank wealth products with about RMB 61.8mn principal and RMB 253,687 of gains.
On Oct 20, 2026, China Tower (00788.HK) reported 9M revenue of RMB71.999bn, down 3.12%, and profit attributable to shareholders of RMB10.817bn, up 24.22%.
On 21 Oct 2026, SANXUN GROUP (06611.HK) said the Listing Committee decided to cancel its listing; it has applied to the Listing Review Committee for a review.
On 21 Oct 2026, ZENGAME (02660.HK) subscribed about US$15mn of US Treasury notes maturing in October 2029; aggregated deals form a discloseable transaction.
